Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
May 2019
Historique:
received: 13 03 2019
accepted: 23 03 2019
revised: 22 03 2019
pubmed: 30 3 2019
medline: 14 8 2019
entrez: 30 3 2019
Statut: ppublish

Résumé

To characterize patterns of language lateralization in a right-handed woman with nonfluent/agrammatic primary progressive aphasia (nfvPPA) clinical picture despite showing a prevalent right-sided brain damage. We report a case of a 58-year-old woman with nfvPPA diagnosis (age at onset = 55) previously described as a crossed aphasia case with progranulin mutation. At 2 years from the first visit, patient underwent 3DT1-weighted and a task-based functional MRI (fMRI). During the fMRI task, she was asked to perform a letter fluency test as the task of interest and to count forward as the control condition. Image processing and data analysis were performed using SPM12 and the effect of each task was tested at p < 0.05 FWE corrected. The structural MRI confirmed a widespread right fronto-temporal atrophy mainly involving the right inferior frontal gyrus. During the letter fluency task, we observed an increased activation centered at the right inferior orbitofrontal gyrus and right middle frontal gyrus. By reducing the threshold, the pattern of functional activation was still dramatically prevalent at the right side. We provided evidence of the right language lateralization in a previously suspected crossed nfvPPA. Despite the long disease duration and the large amount of atrophy at the right side, there was no fMRI evidence of a left-hemisphere contribution to language function. We might speculate that compensatory effects do not appear when the premorbid language lateralization is purely right. The investigation of the underlying functional brain substrates in crossed nfvPPA cases may help understanding disease vulnerability in these neurodegenerative conditions.

Identifiants

pubmed: 30923936
doi: 10.1007/s00415-019-09298-w
pii: 10.1007/s00415-019-09298-w
doi:

Substances chimiques

GRN protein, human 0
Progranulins 0
Oxygen S88TT14065

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

1274-1279

Subventions

Organisme : Ministero della Salute
ID : GR-2011-02351217

Références

AJNR Am J Neuroradiol. 2001 Oct;22(9):1711-8
pubmed: 11673166
Neuroimage. 2003 Feb;18(2):460-7
pubmed: 12595199
Brain. 2006 Jun;129(Pt 6):1371-84
pubmed: 16638796
Behav Neurol. 2007;18(4):239-43
pubmed: 18430983
J Cogn Neurosci. 2009 Oct;21(10):2007-18
pubmed: 19296728
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Neurocase. 2014;20(1):46-52
pubmed: 23058062
J Neurol. 2015 Oct;262(10):2336-45
pubmed: 26194195
AJNR Am J Neuroradiol. 2017 Oct;38(10):E65-E73
pubmed: 28860215
Neurobiol Aging. 2018 Feb;62:191-196
pubmed: 29172163
J Neurol Sci. 2018 Sep 15;392:34-37
pubmed: 30097151
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
Brain Lang. 1998 Sep;64(2):231-56
pubmed: 9710491

Auteurs

Elisa Canu (E)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.

Valentina Bessi (V)

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Michela Leocadi (M)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.

Sonia Padiglioni (S)

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Benedetta Nacmias (B)

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Sandro Sorbi (S)

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.

Massimo Filippi (M)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy.
Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Federica Agosta (F)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina, 60, 20132, Milan, Italy. agosta.federica@hsr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH